KAREN MORIARTY: Open Payments
NPI 1467666347 · BRANFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,988 in 45 payments from 17 companies in 2025. Trend: 2023 $1,493 · 2024 $1,225 · 2025 $1,988
Food & beverage: $1,393Speaker / faculty: $595
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 3 | $823 |
| Novo Nordisk Inc | 8 | $283 |
| Tandem Diabetes Care, Inc. | 4 | $175 |
| Insulet Corporation | 10 | $164 |
| Ascendis Pharma Endocrinology Inc | 2 | $123 |
| Abbott Laboratories | 4 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| ABBVIE INC. | 2 | $39 |
| Mannkind Corporation | 1 | $36 |
| BETA BIONICS, INC. | 1 | $31 |
Products named: Korlym, Ozempic, t:slim X2 Insulin Pump with Control-IQ, Omnipod, Yorvipath, JARDIANCE, FREESTYLE LIBRE 3, Wegovy.
Industry payments across CT — which companies pay providers there.
